Abstract
Commentary: Arguing for Adaptive Clinical Trials in Sepsis.
Highlights
Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology
We completely agree that adaptive designs can be beneficial but they are no magic solutions for all challenges
We comment on four topics: response adaptive randomization (RAR), adaptive enrichment, seamless, and platform designs
Summary
Specialty section: This article was submitted to Inflammation, a section of the journal Frontiers in Immunology. A Commentary on Arguing for Adaptive Clinical Trials in Sepsis by Talisa VB, Yende S, Seymour CW, Angus DC. Commentary: Arguing for Adaptive Clinical Trials in Sepsis.
Sign-in/Register to view highlights & summary Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
